Clinical Laboratory Testing: What Is the Role of Tilt-Table Testing, Active Standing Test, Carotid Massage, Electrophysiological Testing and ATP Test in the Syncope Evaluation?

Progress in Cardiovascular Diseases

Volumn 55, Issue 4, 2013, Pages 418-424

  Blanc, Jean Jacques ^a  

^a UNIVERSITÉ DE BRETAGNE OCCIDENTALE   (France)

Author keywords

Diagnostic tests; Pre test probability; Syncope

Indexed keywords

ADENOSINE TRIPHOSPHATE; GLYCERYL TRINITRATE; ISOPRENALINE;

ACTIVE STANDING TEST; ANGIOCARDIOGRAPHY; ANGIOGRAPHY; ARTICLE; CAROTID MASSAGE; CAROTID SINUS HYPERSENSITIVITY; CAROTID SINUS SYNDROME; CLINICAL EVALUATION; CLINICAL PROTOCOL; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; DRUG INDUCED HEADACHE; ELECTROCARDIOGRAPHY; ELECTROCARDIOGRAPHY MONITORING; ELECTROPHYSIOLOGY; EXERCISE TEST; FAINTNESS; HEADACHE; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE TACHYCARDIA; HUMAN; MASSAGE; METHODOLOGY; ORTHOSTATIC HYPOTENSION; PRACTICE GUIDELINE; SAFETY; SENSITIVITY AND SPECIFICITY; SINUS NODE RECOVERY TIME; TACHYCARDIA; TILT TABLE TEST; TREATMENT INDICATION;

ADENOSINE TRIPHOSPHATE; CAROTID SINUS; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; HUMANS; MASSAGE; PHYSICAL EXAMINATION; POSTURE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SYNCOPE; TILT-TABLE TEST;

EID: 84875243481     PISSN: 00330620     EISSN: 18731740     Source Type: Journal    
DOI: 10.1016/j.pcad.2012.11.002     Document Type: Article

References (45)

1. Moya A., Sutton R., Ammirati F., Blanc J.J., Brignole M., Dahm J.B., et al. Guidelines for the diagnosis and management of syncope (version 2009): the Task Force for the Diagnosis and Management of Syncope of the European Society of Cardiology (ESC). Eur Heart J 2009, 30:2631-2671.
2. Brignole M., Menozzi C., Bartoletti A., et al. A new management of syncope. Prospective systematic guideline based evaluation of patients referred urgently to general hospitals. Eur Heart J 2006, 25:2778-2782.
3. Kenny R.A., Ingram A., Bayliss J., Sutton R. Head-up tilt: a useful test for investigating unexplained syncope. Lancet 1986, 1:1352-1355.
4. Benditt D.G., Ferguson D.W., Grubb B.P., Kapoor W.N., Kugler J., Lerman B.B., et al. Tilt table testing for assessing syncope. American College of Cardiology. J Am Coll Cardiol 1996, 28:263-275.
5. Morillo C.A., Klein G.J., Zandri S., Yee R. Diagnostic accuracy of a low-dose isoproterenol head-up tilt protocol. Am Heart J 1995, 129:901-906.
6. Bartoletti A., Alboni P., Ammirati F., Brignole M., Del Rosso A., Foglia Manzillo G., et al. 'The Italian Protocol': a simplified head-up tilt testing potentiated with oral nitroglycerin to assess patients with unexplained syncope. Europace 2000, 2:339-342.
7. Parry S.W., Gray J.C., Baptist M., O'Shea D., Newton J.L., Kenny R.A. 'Front-loaded' glyceryl trinitrate-head-up tilt table testing: validation of a rapid first line tilt protocol for the diagnosis of vasovagal syncope. Age Ageing 2008, 37:411-415.
8. Brignole M., Menozzi C., Del Rosso A., Costa S., Gaggioli G., Bottoni N., et al. New classification of haemodynamics of vasovagal syncope: beyond the VASIS classification. Analysis of the pre-syncopal phase of the tilt test without and with nitroglycerin challenge. Vasovagal Syncope International Study. Europace 2000, 2:66-76.
9. Deharo J.C., Jego C., Lanteaume A., Djiane P. An implantable loop recorder study of highly symptomatic vasovagal patients: the heart rhythm observed during a spontaneous syncope is identical to the recurrent syncope but not correlated with the head-up tilt test or adenosine triphosphate test. J Am Coll Cardiol 2006, 47:587-593.
10. Brignole M., Sutton R., Menozzi C., Garcia-Civera R., Moya A., Wieling W., et al. International Study on Syncope of Uncertain Etiology 2 (ISSUE 2) Group. Lack of correlation between the responses to tilt testing and adenosine triphosphate test and the mechanism of spontaneous neurally mediated syncope. Eur Heart J 2006, 27:2232-2239.
11. Leman R.B., Clarke E., Gillette P. Significant complications can occur with ischemic heart disease and tilt table testing. Pacing Clin Electrophysiol 1999, 22:675-677.
12. Kenny R.A., O'Shea D., Parry S.W. The Newcastle protocols for head-up tilt table testing in the diagnosis of vasovagal syncope, carotid sinus hypersensitivity, and related disorders. Heart 2000, 83:564-569.
13. de Castro R.R., Mesquita E.T., da Nobrega A.C. Parasympathetic-mediated atrial fibrillation during tilt test associated with increased baroreflex sensitivity. Europace 2006, 8:349-351.
14. Mittal S., Lerman B.B. Tilt-testing: on the road of obsolescence?. J Cardiovasc Electrophysiol 2003, 14:925-926.
15. Sheldon R., Rose S., Flanagan P., Killam S. Risk factors for syncope recurrence after a positive tilt-table test in patients with syncope. Circulation 1996, 93:973-981.
16. Moya A., Permanyer-Miralda G., Sagrista-Sauleda J., Carne X., Rius T., Mont L., et al. Limitations of head-up tilt test for evaluating the efficacy of therapeutic interventions in patients with vasovagal syncope: results of a controlled study of etilefrine versus placebo. J Am Coll Cardiol 1995, 25:65-69.
17. Zaidi A., Clough P., Cooper P., Scheepers B., Fitzpatrick A.P. Misdiagnosis of epilepsy: many seizure-like attacks have a cardiovascular cause. J Am Coll Cardiol 2000, 36:181-184.
18. Petersen M.E., Williams T.R., Sutton R. Psychogenic syncope diagnosed by prolonged head-up tilt testing. QJM 1995, 88:209-213.
19. Heitterachi E., Lord S.R., Meyerkort P., McCloskey I., Fitzpatrick R. BP changes on upright tilting predict falls in older people. Age Ageing 2002, 31:181-186.
20. Freeman R, Wieling W, Axelrod FB, Benditt DG, Benarroch E, Biaggioni I, et al. Consensus statement on definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Autonomic Neuroscience-Basic & Clinical 2011;161(1-2):46-8 and Clinical Autonomic Research. 2011; 21(2):69-72.
21. Mathias C.J. Autonomic diseases: clinical features and laboratory evaluation. J Neurol Neurosurg Psychiatry 2003, 74(Suppl. 3):iii31-iii41.
22. Krediet C.T., Parry S.W., Jardine D.L., Benditt D.G., Brignole M., Wieling W. The history of diagnosing carotid sinus hypersensitivity: why are the current criteria too sensitive?. Europace 2011, 13:14-22.
23. Puggioni E., Guiducci V., Brignole M., Menozzi C., Oddone D., Donateo P., et al. Results and complications of the carotid sinus massage performed according to the 'methods of symptoms'. Am J Cardiol 2002, 89:599-601.
24. Tea S.H., Mansourati J., L'Heveder G., Mabin D., Blanc J.J. New insights into the pathophysiology of carotid sinus syndrome. Circulation 1996, 93:1411-1416.
25. Kerr S.R., Pearce M.S., Brayne C., Davis R.J., Kenny R.A. Carotid sinus hypersensitivity in asymptomatic older persons: implications for diagnosis of syncope and falls. Arch Intern Med 2006, 166:515-520.
26. Munro N.C., McIntosh S., Lawson J., Morley C.A., Sutton R., Kenny R.A. The incidence of complications after carotid sinus massage in older patients with syncope. J Am Geriatr Soc 1994, 42:1248-1251.
27. Davies A.G., Kenny R.A. Frequency of neurologic complications following carotid sinus massage. Am J Cardiol 1998, 81:1256-1257.
28. McAnulty J.H., Rahimtoola S.H., Murphy E., DeMots H., Ritzmann L., Kanarek P.E., et al. Natural history of 'high risk' bundle branch block. Final report of a prospective study. N Engl J Med 1982, 307:137-143.
29. Linzer M., Yang E.H., Estes N.A., Wang P., Vorperian V.R., Kapoor W.N. Unexplained syncope. Clinical Efficacy Assessment Project of the American College of Physicians. Ann Intern Med 1997, 127:76-86.
30. Blanc J.J., L'Her C., Touiza A., Garo B., L'Her E., Mansourati J. Prospective evaluation and outcome of patients admitted for syncope over a 1 year period. Eur Heart J 2002, 23:815-820.
31. Ungar A., Mussi C., Del Rosso A., Noro G., Abete P., Ghirelli L., et al. Diagnosis and characteristics of syncope in older patients referred to geriatric departments. J Am Geriatr Soc 2006, 54:1531-1536.
32. Brignole M., Ungar A., Bartoletti A., Ponassi I., Lagi A., Mussi C., et al. Evaluation of Guidelines in Syncope Study 2 (EGSYS-2) GROUP. Standardized care pathway vs. usual management of syncope patients presenting as emergencies at general hospitals. Europace 2006, 8:644-650.
33. Menozzi C., Brignole M., Alboni P., Boni L., Paparella N., Gaggioli G., et al. The natural course of untreated sick sinus syndrome and identification of the variables predictive of unfavorable outcome. Am J Cardiol 1998, 82:1205-1209.
34. Narula O.S., Samet P., Javier R.P. Significance of the sinus-node recovery time. Circulation 1972, 45:140-158.
35. Scheinman M.M., Peters R.W., Suavé M.J., Desai J., Abbott J.A., Cogan J., et al. Value of the H-Q interval in patients with bundle branch block and the role of prophylactic permanent pacing. Am J Cardiol 1982, 50:1316-1322.
36. Brignole M., Menozzi C., Moya A., Garcia-Civera R., Mont L., Alvarez M., et al. International Study on Syncope of Uncertain Etiology (ISSUE) Investigators. Mechanism of syncope in patients with bundle branch block and negative electrophysiological test. Circulation 2001, 104:2045-2050.
37. Olshansky B., Hahn E.A., Hartz V.L., Prater S.P., Mason J.W. Clinical significance of syncope in the electrophysiologic study versus electrocardiographic monitoring (ESVEM) trial. The ESVEM Investigators. Am Heart J 1999, 137:878-886.
38. Mittal S., Hao S.C., Iwai S., Stein K.M., Markowitz S.M., Slotwiner D.J., et al. Significance of inducible ventricular fibrillation in patients with coronary artery disease and unexplained syncope. J Am Coll Cardiol 2001, 38:371-376.
39. Link M.S., Kim K.M., Homoud M.K., Estes N.A., Wang P.J. Long-term outcome of patients with syncope associated with coronary artery disease and a non diagnostic electrophysiological evaluation. Am J Cardiol 1999, 83:1334-1337.
40. Dickstein K., Vardas P.E., Auricchio A., Daubert J.C., Linde C., McMurray J., et al. Focused Update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association. Eur Heart J 2010, 2010(31):2677-2687.
41. Napolitano C., Bloise R., Monteforte N., Priori S.G. Sudden cardiac death and genetic ion channelopathies: long QT, Brugada, short QT, catecholaminergic polymorphic ventricular tachycardia, and idiopathic ventricular fibrillation. Circulation 2012, 125:2027-2032.
42. Flammang D., Church T., Waynberger M., Chassing A., Antiel M. Can adenosine 5'-triphosphate be used to select treatment in severe vasovagal syndrome?. Circulation 1997, 96:1201-1208.
43. Brignole M., Deharo J.C., De Roy L., Menozzi C., Blommaert D., Dabiri L., et al. Syncope due to idiopathic paroxysmal atrioventricular block: long-term follow-up of a distinct form of atrioventricular block. J Am Coll Cardiol 2011, 58:167-173.
44. Flammang D., Church T.R., De Roy L., Blanc J.J., Leroy J., Mairesse G.H., et al. ATP Multicenter Study. Treatment of unexplained syncope: a multicenter, randomized trial of cardiac pacing guided by adenosine 5'-triphosphate testing. Circulation 2012, 25:31-36.
45. Perennes A., Fatemi M., Borel M.L., Lebras Y., L'Her C., Blanc J.J. Epidemiology, clinical features, and follow-up of patients with syncope and a positive adenosine triphosphate test result. J Am Coll Cardiol 2006, 47:594-597.